🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Matthew James Pianko, MD, details how he determines treatment duration and discontinuation for transplant-eligible multiple myeloma. #mmsm | Matthew Pianko, MD ow.ly/3n8q50LaAIR

1/5 Our paper Clinical Cancer Research shows sustained MRD negativity in MM is associated with stool butyrate and healthier plant based diets. AlexanderLesokhin MD Memorial Sloan Kettering Cancer Center MSKHemOncTrials AACR @HealthTreeMM Multiple Myeloma RF International Myeloma Foundation American Institute for Cancer Research ASH #mmsm aacrjournals.org/clincancerres/…

Thanks Cory Wong for spending 5,019 minutes with me in 2022. I couldn’t stop listening to First Avenue. Your productivity is ridiculously impressive. Looking forward to your Detroit show! #SpotifyWrapped open.spotify.com/artist/6xt9sJm…

Congratulations to our next incoming class of Hematology/Oncology fellows, we look forward to working with you! Nate Wilson Xi Yang Shihan Khan Sadiq Rehmani Gong He, Prarthana Marisa (Reese) Aitken Dalal UM Hematology/Oncology Fellowship U-M Department of Internal Medicine U-M Rogel Cancer Center

master presenter Ajai Chari presenting Talquetamab a bispecific antibody targeting GPRC5D. Amazing 74% ORR and even more remarkable low infection rates grade 3/4 at 17% and 12%. This is remarkable and may likely be the next bispecific and First GPRC5D available #ASH22 #MedIQ22ASH

Great times at the ASH Foundation 5K with the current and former UM fellows! chrissu Jonathan Weiss, MD Lisa Chu, and Sam Reynolds #humidity #ash22

Cancer and Aging Research Group (CARG) #GeriOnc is pleased to announce its 2022 Pilot Grant Awardees. Congratulations to Drs. Ciara Freeman and Matthew Pianko, MD! More info here: mycarg.org/?page_id=172

#ASH22 Hira Mian from McMaster University presents an interim analysis and data from the prospective MFRAIL clinical study, evaluating the association of frailty assessments at at baseline and longitudinally with clinical outcomes in patients with MM #mmsm #MYELOMA

Congratulations Matthew Pianko, MD Hani Hassoun Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease Emphasizing the need for a consensus approach onlinelibrary.wiley.com/doi/10.1002/aj… #mmsm Memorial Sloan Kettering Cancer Center AmericanJournalofHematology Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 MSKHemOncTrials MSK Department of Medicine

EMERSE was instrumental to this project evaluating PJP risk and use of PJP prophylaxis in autoHSCT recipients at UM 2001-2019. Thanks David Hanauer for creating this great resource for clinical research. U-M Department of Internal Medicine Bone Marrow Transplantation

waiting patiently for BCBSM to approve Teclistamab for my patient in great need of this drug. Apparently ‘urgent’ means a 10-14 day review time. Unreasonable prior authorization times are dangerous and irresponsible. What can be done to stop this madness? #mmsm

Our comprehensive review on dietary and microbiome evidence in plasma cell disorders Richa Parikh AlexanderLesokhin MD Francesca Castro and Matteo Bellone MSK Department of Medicine Leukemia Journal #mmsm #microbiome #nutrition #diet rdcu.be/c8JFV

Calling all physicians/advanced practice providers seeing pts with multiple myeloma! We invite you to participate in a quick survey on "Clinician Perspectives on Smoldering Myeloma." Led by Ben Derman Raj Chakraborty Eddie Cliff Survey link: bit.ly/smolderingMM #mmsm

Many oncologists dismiss nutrition as part of a patients overall cancer care plan since they don’t get nutrition training. I discuss nutrition in oncology with Dr Tracy Cushing and Dr Eden English on their podcast. Hope this episode changes your mind. tinyurl.com/y373sz9u 1/3